TipRanks
First Tracks Biotherapeutics Inc (TRAX)
NASDAQ:TRAX
US Market
Want to see TRAX full AI Analyst Report?

First Tracks Biotherapeutics Inc (TRAX) Stock News & Sentiment

45 Followers
Analyst Reiterates Buy on TRAX as IL-15/CD122 Data De-Risk Celiac Program; $57 Price Target Maintained
Premium
Ratings
Analyst Reiterates Buy on TRAX as IL-15/CD122 Data De-Risk Celiac Program; $57 Price Target Maintained
1M ago
First Tracks Biotherapeutics: Buy Rating Reaffirmed with Unchanged $44 Price Target on ANB033 CD122-Targeting Upside and Acquisition Potential
Premium
Ratings
First Tracks Biotherapeutics: Buy Rating Reaffirmed with Unchanged $44 Price Target on ANB033 CD122-Targeting Upside and Acquisition Potential
2M ago
Premium
Ratings
Buy Rating on First Tracks (TRAX) Driven by Strengthening IL-15/CD122 Pathway Validation and Upcoming ANB033 Clinical Catalysts in Celiac Disease and Vitiligo
3M ago

News Score - Last 7 Days

Positive
TRAX
Sector Average
Media Buzz
This Week2 articles
Weekly Average1.5 articles
News Sentiment
This Week100%
Sector Average89%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

FAQ

What is TRAX’s Media Buzz Sentiment?
2 articles about TRAX were published this week. In an average week, 1.5 articles are published.
    What is TRAX’s weekly average amount of articles?
    In an average week, 1.5 articles about TRAX are published.
      What is TRAX’s News Sentiment?
      100% of articles about TRAX were positive this week, compared to its sector average of 89%.
        General Stocks that are Trending in the News
        RPDRapid7
        TERATera Yatirim Menkul Degerler AS
        R2PD34Rapid7 Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.083333 Sh
        T2TD34Trade Desk, Inc. Shs A Unsponsored Brazilian Depositary Receipt Repr 0.01 Sh A
        T1AM34Atlassian Corp Shs A Unsponsored Brazilian Depository Receipt Repr 0.05 Sh A
        Showing the stocks with the most bullish news sentiment over the past week